China

9 June 2020; AFP: Several thousand demonstrators marched in Hong Kong on Tuesday evening -- defying authorities a year after huge pro-democracy protests erupted -- as the movement struggles in the face of arrests, coronavirus bans on crowds and a looming national security law.

Seven months of massive and often violent rallies kicked off on June 9 last year when as many as a million people took to the streets to oppose a bill allowing extraditions to mainland China.

Hong Kong, Jun 9 (AP) A year on from the start of Hong Kong's anti-government protests, the leader of the semi-autonomous Chinese city said Tuesday that all sides should learn from the difficulties and challenging times over the past year.

Everyone has to learn their lesson, including the Hong Kong government, Carrie Lam told reporters before a weekly meeting with advisors.

Hong Kong, Jun 9 (AP) Financially battered Hong Kong airline Cathay Pacific Airways has proposed the government help fund a 39 billion Hong Kong dollar (USD 5 billion) recapitalization plan to help it survive the coronavirus pandemic.



Cathay Pacific said in a stock exchange filing on Tuesday that the plan calls for it to issue shares to raise more than 33 billion Hong Kong dollars (over USD 4.3 billion).

BEIJING, June 9 (Xinhua) -- Chinese State Councilor and Foreign Minister Wang Yi expressed hope that Britain will respect China's legitimate right to safeguard national security in Hong Kong during a phone conversation on Monday with British Foreign Secretary Dominic Raab.

BEIJING (AP) — As the coronavirus spread, the world’s richest communist dug into his deep pockets.

Jack Ma, founder of e-commerce giant Alibaba Group and a member of the ruling Communist Party, helped to pay for 1,000 ventilators delivered to New York in April. Ma’s foundation also is giving ventilators, masks and other supplies in Africa, Latin America and Asia.

BEIJING, Jun 8 (APP): A Chinese Foreign Ministry’s Spokesperson on Monday confirmed that a meeting between senior military officials of China and India was held during weekend and said the two sides were ready to engage in consultations to properly resolve the border standoff.

“On the afternoon of June 6, a meeting was held between the commanders of China and India in Chusul- Moldo region in which the two sides held consultations,” Chinese Foreign Ministry’s Spokesperson Hua Chunying said during her regular briefing held here.

BEIJING, June 8 (NNN-XINHUA) – China will make its COVID-19 vaccine a global public good, when it is ready for application, after successful research and clinical trials, a senior Chinese official said, Sunday.

Wang Zhigang, minister of science and technology, said in Beijing that, international cooperation should be strengthened in vaccine development, clinical trials and application.

Vaccine development should focus on ensuring safety, effectiveness, and accessibility, Wang said.

SHANGHAI, June 7 (Xinhua) -- The first subject from the Shanghai-based Huashan Hospital of Fudan University on Sunday morning received an injection of JS016 -- a recombinant, fully human, monoclonal neutralizing antibody against COVID-19.

It is allegedly the world's first clinical trial for the antibody on a healthy human participant after completing testing on non-human primates, according to the municipal science and technology commission of Shanghai.

BEIJING, June 7 (APP): The Chinese peacekeeping medical team treated Pakistani peacekeeping soldiers who recently sustained injuries in Mikingi, Democratic Republic of Congo, local Chinese media reported.

Two Pakistani soldiers were injured by illegal armed gunmen in an attack on Pakistani peacekeeping camp in Mikingi, Democratic Republic of the Congo, and were soon transported to the secondary hospital of Chinese peacekeeping force, “China Military the only official English-language news website of the Chinese People’s Liberation Army (PLA) reported.

BEIJING, June 6 (Xinhua) -- China has granted market access to a self-developed cancer drug, according to the National Medical Products Administration.

The drug, known as Brukinsa (zanubrutinib) in capsule form, was developed by the biotechnology company BeiGene. It is for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy, and also for adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).